1998
DOI: 10.1097/00000539-199802001-00018
|View full text |Cite
|
Sign up to set email alerts
|

The Incidence of Nausea Following a Remifentanil-Based Anesthetic Regimen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
1999
1999

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Remifentanil may add value with a reported lower incidence of opioid induced emesis. 13 Desflurane and sevoflurane are newer inhalational anaesthetics, marketed in the United States in 1993, and 1995, respectively. Desflurane, at room temperature, is a clear non-flammable liquid with a strong odour.…”
Section: Patient Selectionmentioning
confidence: 99%
“…Remifentanil may add value with a reported lower incidence of opioid induced emesis. 13 Desflurane and sevoflurane are newer inhalational anaesthetics, marketed in the United States in 1993, and 1995, respectively. Desflurane, at room temperature, is a clear non-flammable liquid with a strong odour.…”
Section: Patient Selectionmentioning
confidence: 99%